Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-12-10 16:46 Tx date 2023-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
38 - Redemption, retraction, cancellation, repurchase
|
-$40,000 vol |
$0 | |
Filed 2024-11-21 16:07 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$18,964
+9,074 vol $2.09 each |
675,337 | |
Filed 2024-11-21 16:07 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-9,074 vol |
93,335 | |
Filed 2024-11-21 16:06 Tx date 2024-11-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-9,593 vol |
102,409 | |
Filed 2024-11-20 16:30 Tx date 2024-11-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
112,002 | |
Filed 2024-09-24 17:32 Tx date 2024-09-19 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,500
+3,000 vol $2.50 each |
666,263 | |
Filed 2024-08-21 16:45 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,136 vol |
28,000 | |
Filed 2024-08-21 16:44 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
-6,864 vol |
35,136 | |
Filed 2024-08-21 16:43 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,136 vol |
||
Filed 2024-08-21 16:43 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,864 vol |
||
Filed 2024-08-21 16:29 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,993
+6,864 vol $2.33 each |
663,263 | |
Filed 2024-08-21 16:29 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-7,136 vol |
||
Filed 2024-08-21 16:28 Tx date 2024-08-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,864 vol |
||
Filed 2024-06-28 17:09 Tx date 2024-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,000
+5,000 vol $1.80 each |
656,399 | |
Filed 2024-06-28 17:08 Tx date 2024-06-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,750
+1,000 vol $1.75 each |
651,399 | |
Filed 2023-11-15 15:01 Tx date 2023-11-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+56,001 vol |
56,001 | |
Filed 2023-06-30 16:34 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,510 vol |
650,399 | |
Filed 2023-06-30 16:33 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,490 vol |
42,000 | |
Filed 2023-06-30 16:33 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,510 vol |
49,490 | |
Filed 2023-06-30 16:32 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-30 16:32 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-30 16:30 Tx date 2023-06-29 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,346
+3,800 vol $1.67 each |
643,889 | |
Filed 2023-06-26 19:48 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,490 vol |
||
Filed 2023-06-26 19:48 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,510 vol |
||
Filed 2023-06-26 19:47 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-26 18:27 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,490 vol |
42,000 | |
Filed 2023-06-26 18:27 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
59 - Exercise for cash
|
-7,490 vol |
||
Filed 2023-06-26 18:27 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,510 vol |
49,490 | |
Filed 2023-06-26 18:27 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-6,510 vol |
||
Filed 2023-06-26 18:26 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-26 18:25 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,510 vol |
631,599 | |
Filed 2023-06-26 18:25 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-26 18:24 Tx date 2023-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
+6,510 vol |
||
Filed 2023-06-26 18:08 Tx date 2023-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
+$10,000 vol $102.00 each |
$40,000 | |
Filed 2023-06-26 18:08 Tx date 2023-06-26 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
+$30,000 vol $101.00 each |
$30,000 | |
Filed 2023-06-26 09:49 Tx date 2023-06-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,300
+15,000 vol $1.42 each |
640,089 | |
Filed 2023-02-15 15:34 Tx date 2023-02-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
59 - Exercise for cash
|
-42,018 vol |
0 | |
Filed 2023-02-15 15:33 Tx date 2023-02-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$64,229
+38,232 vol $1.68 each |
625,089 | |
Filed 2023-02-15 15:32 Tx date 2023-02-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-38,232 vol |
42,018 | |
Filed 2022-12-22 09:35 Tx date 2022-12-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
-$16,000 vol $104.00 each |
$5,000 | |
Filed 2022-12-22 09:34 Tx date 2022-12-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,640
-4,000 vol $1.91 each |
588,057 | |
Filed 2022-12-14 14:39 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,640
-4,000 vol $1.91 each |
||
Filed 2022-12-14 14:38 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
-$16,000 vol $104.00 each |
||
Filed 2022-12-14 14:39 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,640
-4,000 vol $1.91 each |
586,857 | |
Filed 2022-12-14 14:39 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,720
-16,000 vol $1.92 each |
||
Filed 2022-12-14 14:38 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
-$16,000 vol $104.00 each |
$0 | |
Filed 2022-12-14 14:38 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
$
-$5,000 vol $104.00 each |
$16,000 | |
Filed 2022-12-14 14:37 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,720
-16,000 vol $1.92 each |
||
Filed 2022-12-14 14:37 Tx date 2022-12-13 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,304
-1,200 vol $1.92 each |
590,857 | |
Filed 2022-11-30 11:49 Tx date 2022-11-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+56,000 vol |
56,000 | |
Filed 2022-11-30 11:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-09-21 15:05 Tx date 2022-09-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,900
+10,000 vol $1.19 each |
592,057 | |
Filed 2022-08-30 10:34 Tx date 2022-08-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+37,794 vol |
582,057 | |
Filed 2022-08-30 10:33 Tx date 2022-08-25 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-80,250 vol |
80,250 | |
Filed 2022-06-29 08:48 Tx date 2022-06-28 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+10,000 vol $2.00 each |
544,263 | |
Filed 2022-01-04 10:57 Tx date 2021-12-31 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,700
+5,000 vol $2.54 each |
534,263 | |
Filed 2021-12-28 15:03 Tx date 2021-12-20 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
97 - Other
|
+53,500 vol |
85,935 | |
Filed 2021-12-20 16:32 Tx date 2021-12-17 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,750
+5,000 vol $2.55 each |
529,263 | |
Filed 2021-11-30 17:26 Tx date 2021-11-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+160,500 vol |
524,263 | |
Filed 2021-11-30 17:25 Tx date 2021-11-24 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-160,500 vol |
160,500 | |
Filed 2021-11-17 18:22 Tx date 2021-11-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,434
+5,000 vol $2.89 each |
363,763 | |
Filed 2021-11-12 14:56 Tx date 2021-11-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,200
+5,000 vol $3.04 each |
358,763 | |
Filed 2021-10-05 15:20 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
353,763 | |
Filed 2021-10-05 15:18 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
||
Filed 2021-10-05 14:57 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
353,763 | |
Filed 2021-10-05 14:57 Tx date 2021-09-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$631.12
+196 vol $3.22 each |
||
Filed 2021-09-24 14:28 Tx date 2021-09-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+5,000 vol $3.00 each |
353,567 | |
Filed 2021-09-13 09:22 Tx date 2021-09-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
10 - Acquisition or disposition in the public market
|
+$21,000 vol |
$21,000 | |
Filed 2021-09-13 08:49 Tx date 2018-10-16 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures 6% Unsecured
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-08-19 15:47 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$13,874
+5,000 vol $2.77 each |
348,567 | |
Filed 2021-08-19 15:46 Tx date 2021-08-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,435
+500 vol $2.87 each |
343,567 | |
Filed 2021-06-30 14:09 Tx date 2021-06-30 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,333
+2,500 vol $7.33 each |
343,067 | |
Filed 2021-06-22 18:45 Tx date 2021-06-22 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,780
+1,800 vol $7.10 each |
340,567 | |
Filed 2021-06-22 15:04 Tx date 2021-06-21 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,580
+2,000 vol $7.29 each |
338,767 | |
Filed 2021-06-22 15:03 Tx date 2021-06-18 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,240
+1,000 vol $7.24 each |
336,767 | |
Filed 2021-03-15 11:04 Tx date 2021-03-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,739
+700 vol $6.77 each |
335,767 | |
Filed 2021-03-08 16:13 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,244
+300 vol $7.48 each |
335,067 | |
Filed 2021-03-08 16:13 Tx date 2021-03-08 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$25,891
+3,500 vol $7.40 each |
334,767 | |
Filed 2020-03-24 15:20 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,306
+1,900 vol $1.74 each |
56,935 | |
Filed 2020-03-24 15:20 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$173.00
+100 vol $1.73 each |
55,035 | |
Filed 2020-03-24 15:19 Tx date 2020-03-23 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+4,000 vol $1.50 each |
54,935 | |
Filed 2020-03-13 17:07 Tx date 2020-03-11 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+2,000 vol $3.00 each |
50,935 | |
Filed 2020-03-09 17:29 Tx date 2020-03-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,017
+300 vol $3.39 each |
48,935 | |
Filed 2020-03-09 17:28 Tx date 2020-03-09 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,980
+4,700 vol $3.40 each |
48,635 | |
Filed 2020-03-09 17:27 Tx date 2020-03-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,480
+2,000 vol $3.74 each |
43,935 | |
Filed 2020-03-04 17:53 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,110
+1,800 vol $3.95 each |
41,735 | |
Filed 2020-03-04 17:50 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$788.00
+200 vol $3.94 each |
41,935 | |
Filed 2020-03-04 17:50 Tx date 2020-03-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,020
+1,800 vol $3.90 each |
||
Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,945
+500 vol $3.89 each |
39,935 | |
Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+200 vol $4.00 each |
39,435 | |
Filed 2020-03-04 17:45 Tx date 2020-03-03 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,770
+4,300 vol $3.90 each |
39,235 | |
Filed 2019-09-16 18:34 Tx date 2019-09-12 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,810
+1,000 vol $3.81 each |
34,935 | |
Filed 2019-09-10 18:35 Tx date 2019-09-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,875
+500 vol $3.75 each |
||
Filed 2019-09-10 18:35 Tx date 2019-09-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+500 vol $3.76 each |
||
Filed 2019-09-10 18:34 Tx date 2019-09-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,875
+500 vol $3.75 each |
||
Filed 2019-09-10 18:34 Tx date 2019-09-10 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,880
+500 vol $3.76 each |
||
Filed 2019-09-06 16:07 Tx date 2019-09-06 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,873
+500 vol $3.75 each |
33,935 | |
Filed 2019-09-06 16:02 Tx date 2019-09-04 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,835
+1,000 vol $3.83 each |
33,435 | |
Filed 2019-08-29 18:21 Tx date 2019-08-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,745
+5,000 vol $3.75 each |
331,267 | |
Filed 2019-08-29 18:20 Tx date 2019-08-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,869
+500 vol $3.74 each |
326,267 | |
Filed 2019-08-29 18:19 Tx date 2019-08-27 |
$MDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$380.00
+100 vol $3.80 each |
325,767 | |
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
||
Filed 2019-03-05 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: d'Entremont Family Trust (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-9,356,676 vol |
668,334 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicolle d'Entremont (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,867 vol |
133 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-4,559,335 vol |
325,667 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+321,000 vol |
321,000 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-454,085 vol |
32,435 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,867 vol |
133 | |
Filed 2018-12-21 Tx date 2018-12-19 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
37 - Stock split or consolidation
|
-454,085 vol |
32,435 | |
Filed 2018-12-21 Tx date 2018-10-16 |
$PDP
Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell - RRSP (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
486,520 | ||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Nicolle d'Entremont (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Kerry Bakewell (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,885,002 | ||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: d'Entremont Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,025,010 | ||
Filed 2018-10-19 Tx date 2018-10-16 |
$PDP
Pediapharm Inc. |
d'Entremont, Kenneth
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
486,520 |